Erythropoietin in the critically ill – is it more than just blood?

Erythropoietin (EPO) has been in clinical use for the treatment of anemia for over 15 years. Recently it has been demonstrated that EPO has actions other than stimulating the bone marrow. It has been suggested that due to its tissue protecting effect, EPO may be effective in improving outcome in the...

Descripción completa

Detalles Bibliográficos
Autor principal: Corwin, Howard L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1065033/
https://www.ncbi.nlm.nih.gov/pubmed/15469592
http://dx.doi.org/10.1186/cc2949
Descripción
Sumario:Erythropoietin (EPO) has been in clinical use for the treatment of anemia for over 15 years. Recently it has been demonstrated that EPO has actions other than stimulating the bone marrow. It has been suggested that due to its tissue protecting effect, EPO may be effective in improving outcome in the critically ill.

Ejemplares similares